0001209191-12-022329.txt : 20120405 0001209191-12-022329.hdr.sgml : 20120405 20120405163234 ACCESSION NUMBER: 0001209191-12-022329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120403 FILED AS OF DATE: 20120405 DATE AS OF CHANGE: 20120405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FINKELSTEIN J J CENTRAL INDEX KEY: 0001125610 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 12746030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019611992 MAIL ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 4 1 doc4.xml FORM 4 SUBMISSION X0305 4 2012-04-03 0 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0001125610 FINKELSTEIN J J C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 1 1 0 0 President and CEO Stock Option (right to buy) 0.16 2012-04-03 4 A 0 35000 0.00 A 2019-04-03 Common Stock 35000 35000 D The shares underlying this option vest in full on June 30, 2012, subject to the reporting person's continued service with the issuer. /s/ J.J. Finkelstein 2012-04-05